APC corporate supporter Topi-CLICK has recently increased its support for APC, moving from a $10,000 investment to an annual $25,000 investment. read more →
APC and NCPA have sent a joint letter to the Oregon Board of Pharmacy expressing concern about the agency’s recent fiscal impact request regarding proposed rules on pharmacist licensure and counseling requirements. read more →
Today is the last day for members of Congress to add their names to a joint letter to FDA in support of maintaining access to compounded hormones. The letter is led by Rep. Jennifer Wexton (D-VA). read more →
Earlier this week, FDA issued its first public statement on semaglutide compounding. The statement elaborates on what the agency said in its April letter to NABP on the subject. read more →
Send a message to your respective members of Congress, asking them to support legislative language that will allow pharmacy compounders to help fill urgent gaps in the drug supply chain. read more →
APC members are invited to attend Informa Connect’s two-day program, Compounding Pharmacy Compliance at a special, members-only rate (use code 23A4PC15 to receive 15 percent off your registration fee). read more →
Earlier this week, APC’s Executive Committee and Federal Legislative Committee leaders met virtually with FDA’s Office of Compounding Quality + Compliance team to discuss a range of issues impacting pharmacy compounding. read more →
